Revelation Biosciences Stock (NASDAQ:REVB)


RevenueOwnershipFinancialsChart

Previous Close

$0.83

52W Range

$0.70 - $25.26

50D Avg

$1.07

200D Avg

$3.81

Market Cap

$3.06M

Avg Vol (3M)

$1.66M

Beta

0.18

Div Yield

-

REVB Company Profile


Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. The company engages in developing therapeutic product candidates, including REVTx-99b that is in a Phase Ib clinical trial for the prevention or treatment of chronic nasal congestion and allergic rhinitis; and REVTx-200, a nonclinical stage product for intranasal therapy. It is also involved in developing REVTx-300, a non-clinical stage product that is being developed as a potential therapy for the treatment of chronic organ disease, including chronic kidney disease and non-alcoholic steatohepatitis; and REVDx-501, a rapid test kit, which is a point of care in vitro diagnostic test that has the potential to detect respiratory viral infections, such as SARS-CoV-2, Influenza A, Influenza B, parainfluenza, or respiratory syncytial virus. The company was founded in 2020 and is based in San Diego, California.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

9

IPO Date

Nov 17, 2020

Website

REVB Performance


REVB Financial Summary


Dec 23Dec 22Dec 21
Revenue---
Operating Income$-8.66M$-10.86M$-11.95M
Net Income$-120.25K$-10.79M$-11.99M
EBITDA$-8.66M$-10.84M$-11.93M
Basic EPS$-0.53$-20.05$-32.41
Diluted EPS$-0.53$-20.03$-32.41

Fiscal year ends in Dec 23 | Currency in USD

Peer Comparison


TickerCompany
ZVSAZyVersa Therapeutics, Inc.
BWVOnconetix, Inc.
KPRXKiora Pharmaceuticals, Inc.
PXMDPaxMedica, Inc. Common Stock
PHIOPhio Pharmaceuticals Corp.
QNRXQuoin Pharmaceuticals, Ltd.
RNAZTransCode Therapeutics, Inc.
HILSTharimmune, Inc.
VRAXVirax Biolabs Group Limited
CYTOAltamira Therapeutics Ltd.
SONNSonnet BioTherapeutics Holdings, Inc.
ZURAZura Bio Limited